Natixis’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-95
| Closed | -$1.78K | – | 1109 |
|
|
2024
Q1 | $1.78K | Sell |
95
-30,905
| -100% | -$579K | ﹤0.01% | 932 |
|
|
2023
Q4 | $672K | Hold |
31,000
| – | – | ﹤0.01% | 564 |
|
|
2023
Q3 | $638K | Buy |
+31,000
| New | +$638K | ﹤0.01% | 558 |
|
|
2022
Q3 | – | Sell |
-35,200
| Closed | -$1.14M | – | 1053 |
|
|
2022
Q2 | $1.14M | Buy |
+35,200
| New | +$1.14M | ﹤0.01% | 750 |
|
|
2021
Q4 | – | Sell |
-34,900
| Closed | -$1.55M | – | 1335 |
|
|
2021
Q3 | $1.55M | Buy |
+34,900
| New | +$1.55M | 0.01% | 784 |
|